Ocular Therapeutix Inc (OCUL)
6.115
-0.18
(-2.78%)
USD |
NASDAQ |
May 21, 16:00
6.115
0.00 (0.00%)
After-Hours: 16:21
Ocular Therapeutix SG&A Expense (Quarterly): 24.33M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 24.33M |
December 31, 2023 | 17.27M |
September 30, 2023 | 17.90M |
June 30, 2023 | 19.36M |
March 31, 2023 | 19.96M |
December 31, 2022 | 18.88M |
September 30, 2022 | 18.72M |
June 30, 2022 | 17.93M |
March 31, 2022 | 16.62M |
December 31, 2021 | 16.67M |
September 30, 2021 | 17.65M |
June 30, 2021 | 16.99M |
March 31, 2021 | 15.75M |
December 31, 2020 | 13.39M |
September 30, 2020 | 12.48M |
June 30, 2020 | 11.30M |
March 31, 2020 | 12.31M |
December 31, 2019 | 12.69M |
September 30, 2019 | 12.93M |
June 30, 2019 | 12.28M |
March 31, 2019 | 8.705M |
December 31, 2018 | 7.412M |
September 30, 2018 | 5.514M |
Date | Value |
---|---|
June 30, 2018 | 5.314M |
March 31, 2018 | 5.488M |
December 31, 2017 | 5.182M |
September 30, 2017 | 7.468M |
June 30, 2017 | 10.56M |
March 31, 2017 | 9.303M |
December 31, 2016 | 5.528M |
September 30, 2016 | 3.917M |
June 30, 2016 | 4.465M |
March 31, 2016 | 3.795M |
December 31, 2015 | 3.733M |
September 30, 2015 | 3.249M |
June 30, 2015 | 3.271M |
March 31, 2015 | 2.764M |
December 31, 2014 | 2.874M |
September 30, 2014 | 2.405M |
June 30, 2014 | 1.731M |
March 31, 2014 | 1.885M |
December 31, 2013 | 0.577M |
September 30, 2013 | 0.651M |
June 30, 2013 | 0.585M |
March 31, 2013 | 0.573M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
11.30M
Minimum
Jun 2020
24.33M
Maximum
Mar 2024
16.27M
Average
16.83M
Median
SG&A Expense (Quarterly) Benchmarks
Amgen Inc | 1.808B |
Assertio Holdings Inc | 18.52M |
CytomX Therapeutics Inc | 7.754M |
EyePoint Pharmaceuticals Inc | 14.11M |
Cormedix Inc | 15.05M |